Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Xinyang's "Heavy Asset Game" is urgently awaiting a profitable moment
Last quarter, So-Young (Xinyang) experienced its most difficult financial period.
At that time, So-Young was at a crossroads, transitioning from platform advertising and heavy-asset chain medical aesthetic services, with the pain of transformation particularly intense.
Because of its involvement in offline light medical aesthetics, competing with its original medical aesthetic clients, this inevitably accelerated the loss of traditional advertising clients, making the transition especially painful.
Now, with the growth of its offline chain business, So-Young’s tough times have finally reached a turning point.
In 2025, So-Young’s revenue reached 1.523 billion yuan, a 3.87% increase year-over-year. In the fourth quarter alone, revenue was 461 million yuan, up over 20% year-over-year.
The heavily invested offline light medical aesthetic chain business has finally supported half of the company’s operations. In Q4 2025, revenue from So-Young’s medical aesthetic medical services (i.e., offline store business) reached 248 million yuan, a 205.3% increase year-over-year, accounting for over 50% of total revenue for the first time.
By the end of 2025, So-Young had 49 offline stores.
Although the business restructuring has shown initial results, So-Young has not yet fully escaped the loss cycle, with a net loss of 242 million yuan in 2025.
In response, So-Young told AllWeather Tech that it aims to achieve quarterly profitability by Q4 2026.
To turn losses into profits, So-Young’s core drivers are “improving efficiency of existing stores” and “expanding into new stores.”
In 2026, So-Young plans to open no fewer than 35 new stores, intensifying its network in first-tier cities while focusing on expanding into high-quality second-tier cities.
During a conference call on March 25, So-Young’s management explained the business logic behind increasing its presence in second-tier cities: Compared to first-tier cities, second-tier cities in China still have significant gaps in medical delivery capacity and operational standards in the medical aesthetics field. So-Young’s “standardized delivery capability” can ensure that stores in second-tier cities provide services and results comparable to those in first-tier cities.
Further, according to So-Young’s management, as of December 2025, the average sales per square meter in mature second-tier city stores like Wuhan Tiandi and Changsha were around 7,000 yuan. Recently opened second-tier city stores, such as the Suzhou Suyue Plaza store, achieved monthly revenue exceeding one million yuan within three months, demonstrating the feasibility of replicating the model in second-tier cities.
“From the profitability of mature stores in second-tier cities, due to lower wages for medical staff and rent levels compared to first-tier cities, profit margins in second-tier city stores are even slightly higher,” said So-Young’s management.
With the benefits of sinking into second-tier cities and higher profit margins, whether So-Young can successfully implement its profitability model is now under close watch.
Risk Warning and Disclaimer
Market risks exist; investments should be cautious. This article does not constitute personal investment advice and does not consider individual users’ specific investment goals, financial situations, or needs. Users should consider whether any opinions, viewpoints, or conclusions in this article are suitable for their particular circumstances. Invest at your own risk.